Radiomics Signature Predicts the Recurrence-Free Survival in Stage I Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiomics Signature Predicts the Recurrence-Free Survival in Stage I Non-Small Cell Lung Cancer

Published:2020-06 Issue:6 Volume:109 Page:1741-1749
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Wang Tingting,Deng Jiajun,She Yunlang,Zhang Lei,Wang Bin,Ren Yijiu,Wu Junqi,Xie Dong,Sun Xiwen,Chen Chang

Funder

Shanghai Municipal Health Commission

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference30 articles.

1. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

2. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N Engl J Med,2011

3. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence;Hung;Thorax,2009

4. Prognostic factors for post recurrence survival in resected pathological stage I non-small cell lung cancer;Kubouchi;Yonago Acta Med,2017

5. Influence of ground glass opacity and the corresponding pathological findings on survival in patients with clinical stage I non-small cell lung cancer;Aokage;J Thorac Oncol,2018

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organomics;Clinical Nuclear Medicine;2024-10

2. Integrating MR radiomics and dynamic hematological factors predicts pathological response to neoadjuvant chemoradiotherapy in esophageal cancer;Heliyon;2024-07

3. Quantitative radiomics analysis of imaging features in adults and children Mycoplasma pneumonia;Frontiers in Medicine;2024-05-20

4. Organomics: A concept reflecting the importance of PET/CT healthy organ radiomics in non-small cell lung cancer prognosis prediction using machine learning;2024-05-15

5. Radiomic analysis of patient and inter-organ heterogeneity in response to immunotherapies and BRAF targeted therapy in metastatic melanoma;2024-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3